Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00371527 · ClinicalTrials.gov registry record · NA
Effect of Ipratropium on Acute Bronchitis in Subjects Without Underlying Lung Disease
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT00371527 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 200 participants.
The verdict
NCT00371527, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
ABSTRACT CONTEXT: Inappropriate antibiotic prescriptions for acute bronchitis is a major public health concern because of antibiotic resistance. Effective therapies for managing the symptoms of acute bronchitis are lacking, however. OBJECTIVE: Determine if patients with acute bronchitis have better symptom control when treated with inhaled ipratropium. DESIGN, SETTING, PARTICIPANTS: COUGH STOP was a randomized, double blind, placebo controlled trial comparing ipratropium with placebo in acute bronchitis. Subjects were referred by their primary care provider or from urgent care clinics at a single institution. Subjects had been diagnosed with acute bronchitis and had no significant co-morbidities. INTERVENTION: Subjects received ipratropium or placebo inhalers, administering 2 puffs four times daily. A structured telephone interview took place 2, 4, and 8 days after enrollment. Medical records were reviewed at 60 days. OUTCOME: The primary endpoint was improvement in cough symptomology; secondary endpoints included subsequent antibiotic prescriptions and "well being."
Interventions
- DRUG ipratropium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2002-10 |
| Est. Completion | 2004-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00371527
The ClinicalTrials.gov registry entry for NCT00371527 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ipratropium is the first listed.
NCT00371527 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00371527 about?
NCT00371527 is a clinical study titled "Effect of Ipratropium on Acute Bronchitis in Subjects Without Underlying Lung Disease". ABSTRACT CONTEXT: Inappropriate antibiotic prescriptions for acute bronchitis is a major public health concern because of antibiotic resistance. Effective therapies for managing the symptoms of acute bronchitis are lacking, however. OBJECTIVE: Determine if patients with acute bronchitis have better...
What is the current status of trial NCT00371527?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2002-10. Estimated completion is 2004-01.
What interventions are being tested in trial NCT00371527?
The interventions under investigation include: ipratropium (DRUG).
Who is sponsoring clinical trial NCT00371527?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.